Podcasts

Episode 7 | Lung cancer screening works!

In this episode, Prof Emily Stone and Prof Kwun Fong, both long time advocates and researchers in early screening discuss the challenges of implementing a lung cancer screening program.

Lung cancer screening works!

Episode Summary

In this episode Prof Emily Stone interviews Prof Kwun Fong to discuss the challenges of implementing a lung cancer screening program. Both are long time advocates and researchers in early screening for lung cancer. Lung cancer screening works. Earlier detection of lung cancer presents a vastly different prognosis. Stage I disease has a median 5 year survival of greater than 65%, whereas metastatic disease has a 5 year median survival rate of 15-20%. It is time to shift the perception of a lung cancer diagnosis to that of a treatable cancer with a potential cure, through a combination of early-stage detection, and effective communication that newer treatments offer better survival and QoL. The recently released Cancer Australia Report on lung cancer screening has been presented to the Health Minister and is awaiting actions.

Show Hosts

This episode’s host are:

  • Prof Emily Stone, Deputy Chair, TOGA; Respiratory Physician, Senior Staff Specialist and Head of Thoracic Medicine, Department of Thoracic Medicine and Lung Transplantation, St Vincent’s Hospital Sydney; conjoint Senior Lecturer, University of New South Wales; Chair, St Vincent’s Hospital Lung Cancer Multidisciplinary team
  • Prof Kwun Fong, Thoracic and Sleep Physician, The Prince Charles Hospital

Play Episode 7 | Lung cancer screening works!

More Podcasts

In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore, along with thoracic oncologists Dr. Malinda Itchins and A/Prof Surein Arulananda, delve into
In this episode of Conversations in Lung Cancer Research, A/Prof Mel Moore interviews Prof Michael Boyer, AM about his extensive career in medical oncology and
In this introductory episode, A/Prof Mel Moore, announces the evolution of TOGA podcasts to 'Conversations in Lung Cancer Research.'
Dr Rebecca Tay is joined by Professor Ben Solomon and A/Prof Michael Ng to discuss clinical and genetic factors affecting treatment choice for ALK-Positive NSCLC
Dr Deme Karikios is joined by Dr Lauren Brown and Dr Stephen Barnett to discuss IO in early-stage NSCLC in the Australian context.
A/Prof Rachel Wong is joined by Dr Patrick Hosking, Dr Mal Itchins, and Dr Sagun Parakh discuss the diagnostic markers when identifying LC-NEC.